Scleroderma-like drug reaction to paclitaxel (taxol®) [10]

British Journal of Dermatology

Volumn 147, Issue 3, 2002, Pages 619-620

  Lauchli S ^a   Trueb R M ^a   Fehr, M ^b   Hafner, J ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; PACLITAXEL;

AGED; APPENDECTOMY; AREA UNDER THE CURVE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FLUID RETENTION; FOLLOW UP; HUMAN; HYSTERECTOMY; LETTER; PHOTOCHEMOTHERAPY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PUVA; SCLERODERMA; SCLEROSIS; SKIN FIBROSIS; SKIN MANIFESTATION; SKIN ULCER;

EID: 0036051426     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.488210.x     Document Type: Letter

References (5)

1. Acute cutaneous reactions to docetaxel, a new chemotherapeutic agent
2. Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases
3. Cutaneous fibrosis induced by docetaxel: A case report
4. Scleroderma in association with the use of docetaxel (taxotere) for breast cancer
5. Scleroderma and ovarian carcinoma